Bivalent DNA SARS-CoV-2 vaccine induces strong humoral and cellular immunity in mice

By | June 24, 2021
A team of UK-based scientists has developed and validated a DNA vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that encodes both spike receptor-binding domain (RBD) and nucleocapsid of the virus as vaccine immunogens.